- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04163081
INITIATE 연구: 응급실에 입원한 흡연자를 위한 니코틴 의존 치료 시작 (INITIATE)
The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED) and other high-volume hospital and community ambulatory care settings. The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs, community healthcare centers, and other inpatient and outpatient clinics in Canada offer tobacco-use interventions. In order for clinicians to offer quit smoking support, interventions need to be simple given the realities of these high-volume environments. Considering that stopping smoking improves health outcomes, that tobacco-use is an important cause of preventable ED use, and the volume of smokers, Canadian EDs and other high-volume hospital and community ambulatory care settings are a missed opportunity in the initiation of quit smoking support. Our intervention has been designed to optimize uptake and smoking abstinence by including the most effective evidence-based behavioural and drug-related approaches, removing specific barriers and challenges that smokers face when trying to quit (e.g., affordability, low confidence and motivation), while packaging the intervention in a quick-to-initiate manner, making it ideal for fast-paced, complex environments.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Evyanne Wooding, R.Kin
- 전화번호: 17596 613-696-7000
- 이메일: ewooding@ottawaheart.ca
연구 연락처 백업
- 이름: Chantelle Masterson, BPhil
- 전화번호: 19157 613-696-7000
- 이메일: cmasterson@ottawaheart.ca
연구 장소
-
-
Ontario
-
Ottawa, Ontario, 캐나다
- 모병
- University of Ottawa Heart Institute
-
연락하다:
- Dr. Kerri-Anne Mullen
- 전화번호: 613-696-7000 ext.19095
- 이메일: KMullen@ottawaheart.ca
-
Ottawa, Ontario, 캐나다
- 모병
- Civic Hospital
-
연락하다:
- Dr. Venkatesh Thiruganasambandamoorthy
- 전화번호: 6137985555,17023
- 이메일: vthirug@toh.ca
-
Ottawa, Ontario, 캐나다
- 모병
- General Hospital
-
연락하다:
- Dr. Venkatesh Thiruganasambandamoorthy
- 전화번호: 6137985555,17023
- 이메일: vthirug@toh.ca
-
Ottawa, Ontario, 캐나다
- 모병
- Riverside Hospital
-
연락하다:
- Dr. Venkatesh Thiruganasambandamoorthy
- 전화번호: 6137985555,17023
- 이메일: vthirug@toh.ca
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Current daily smoker (smokes ≥ 5 cigarettes per day);
- ≥ 18 years of age (the age of majority in Ontario);
- For ED sites only, assigned a CTAS level of 2-5 (emergent to non-urgent);
- Able to read and understand English or French;
- Resides in Ontario and eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences [ICES]);
- Available and willing to participate in follow-up assessments over the next 12 months;
- Has access to a telephone or computer;
- Able to provide informed consent
Exclusion Criteria:
- Currently participating in this or another smoking cessation study;
- For ED sites only, assigned a CTAS level of 1 (resuscitation - the most seriously ill patients with highest likelihood of hospital admission) or in psychiatric emergency unit;
- Pregnant, planning to become pregnant over the next year, or breastfeeding;
- Has morbid illness which will prevent completion of 26-week follow-up (e.g., receiving palliative care);
- In the opinion of the attending physician, manifests acute physical and/or psychiatric illness or has cognitive impairment that would preclude participation in/benefit from the intervention.
- Scheduled for a known elected surgery, procedure, or future hospitalization during the study period.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Quit Card Intervention (QCI)
Study intervention group. |
The intervention is comprised of a behavioural incentive in the form of a gift card as well as tailored smoking cessation counseling. Eligible consenting smokers randomized to the QCI group will receive: a "Quit Card" (a gift card worth $300 that can be used to buy nicotine replacement therapies at any pharmacy); self-help information; and, enrollment in six months of telephone follow-up support tailored by treatment goal with a Nicotine Addiction Treatment Specialist. |
|
간섭 없음: Usual Care (UC)
Study control group. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Smoking Abstinence
기간: 26 weeks (6 months) after study enrollment
|
Smoking abstinence at 26 weeks, biochemically verified using an expired air carbon monoxide (CO) test |
26 weeks (6 months) after study enrollment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Prolonged Abstinence
기간: 4, 26, and 52 weeks after study enrollment
|
Prolonged (since last time point) smoking abstinence, at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Point Prevalence Abstinence
기간: 4, and 52 weeks after study enrollment
|
Point prevalence smoking abstinence, at 4, and 52 weeks |
4, and 52 weeks after study enrollment
|
|
Smoking Reduction
기간: 4, 26, and 52 weeks after study enrollment
|
Smoking reduction (i.e., change in number of daily cigarettes), at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Number of Quit Attempts
기간: 4, 26, and 52 weeks after study enrollment
|
Number of quit attempts since study entry, at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Cessation Medication and/or E-cigarette Use
기간: 4, 26, and 52 weeks after study enrollment
|
Use of smoking cessation medication and/or e-cigarette, at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Use of Behavioural Supports
기간: 4, 26, and 52 weeks after study enrollment
|
Use of behavioural supports (e.g., counseling, quit lines), at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Health-Related Quality of Life
기간: 52 weeks after study enrollment
|
Health-related quality of life (HR-QoL), at 52 weeks. This will be measured using the Hospital Anxiety and Depression Scale (HADS), designed to identify and measure the levels of anxiety and depression among individuals in non-psychiatric hospital settings, and the Health Questionnaire Assessment (EQ-5D-5L), using five graded severity levels to summarize perceived health across five foundational dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. |
52 weeks after study enrollment
|
|
Health Services Outcomes - ED visits
기간: 4, 26, and 52 weeks after study enrollment
|
Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) visits to ED at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Health Services Outcomes - Hospital Admissions
기간: 4, 26, and 52 weeks after study enrollment
|
Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) admissions to hospital at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Health Services Outcomes - Deaths
기간: 4, 26, and 52 weeks after study enrollment
|
Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) deaths at 4, 26, and 52 weeks |
4, 26, and 52 weeks after study enrollment
|
|
Cost-Effectiveness Ratios
기간: 52 weeks after study enrollment
|
Cost-effectiveness ratios related to health services at 52 weeks |
52 weeks after study enrollment
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Kerri-Anne Mullen, PhD, Ottawa Heart Institute Research Corporation
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .